Intensity Therapeutics (INTS) Shares Outstanding (Diluted) (2022 - 2026)
Intensity Therapeutics' Shares Outstanding (Diluted) was 2.71 million in Q2 2026, down 85.7% from 18.87 million a year earlier but up 6.8% from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Intensity Therapeutics came in at 1.36 million, down 90.2% from FY2024.
- Shares Outstanding (Diluted) shows a three-year compound annual growth rate of -26.5% (FY2022 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 13.91 million in FY2024 (+61.4%), 8.62 million in FY2023 (+152.7%) and 3.41 million in FY2022.
- Quarterly Shares Outstanding (Diluted) has moved between 1.36 million (Q4 2025) and 43.04 million (Q3 2025) over five years.
- Compared with a year earlier, Shares Outstanding (Diluted) has declined for three straight quarters, with growth averaging 7.9% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q1 2024 (growth of 302.0%); the worst was Q4 2025 (a decline of 90.2%).
- Per Business Quant data, INTS's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 2.53 million (Q1 2026), 1.36 million (Q4 2025) and 43.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Intensity Therapeutics | 10.01 Mn | 10.01 Mn | - | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 43.04 Mn |
| Jun 30, 2025 | 18.87 Mn |
| Mar 31, 2025 | 15.17 Mn |
| Dec 31, 2024 | 13.91 Mn |
| Sep 30, 2024 | 13.80 Mn |
| Jun 30, 2024 | 13.71 Mn |
| Mar 31, 2024 | 13.71 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | 13.66 Mn |
| Jun 30, 2023 | 3.52 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 3.41 Mn |
| Jun 30, 2022 | 3.41 Mn |
API Access
Intensity Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();